Associations between obstructive sleep apnea and painful temporomandibular disorder: a systematic review

Jeong-Hyun Kang; Jeong Keun Lee

doi:10.5125/jkaoms.2022.48.5.259

Journal List > J Korean Assoc Oral Maxillofac Surg > v.48(5) > 1516080074

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Kang and Lee: Associations between obstructive sleep apnea and painful temporomandibular disorder: a systematic review

Review Article

J Korean Assoc Oral Maxillofac Surg 2022;48(5):259-266.

Published online: 31 October 2022

DOI: https://doi.org/10.5125/jkaoms.2022.48.5.259

Associations between obstructive sleep apnea and painful temporomandibular disorder: a systematic review

Jeong-Hyun Kang¹

, Jeong Keun Lee^2,

¹Clinic of Oral Medicine and Orofacial Pain, Institute of Oral Health Science, Ajou University School of Medicine, Suwon, Korea

²Department of Oral and Maxillofacial Surgery, Institute of Oral Health Science, Ajou University School of Medicine, Suwon, Korea

Jeong Keun Lee, Department of Oral and Maxillofacial Surgery, Institute of Oral Health Science, Ajou University School of Medicine, 164 WorldCup-ro, Yeongtong-gu, Suwon 16499, Korea, TEL: +82-31-219-5333, E-mail: arcady@ajou.ac.kr, ORCID: https://orcid.org/0000-0002-5561-6297

Received 20 September 2022 Revised 27 September 2022 Accepted 28 September 2022

(open-access):

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

The relationship between obstructive sleep apnea (OSA) and diverse types of pain conditions have been proposed. However, no consensus on the relationship between OSA and painful temporomandibular disorders (TMDs) has been established. Therefore, this systematic review has been conducted to review the existing literatures and provide comprehensive synthesis of such literatures about OSA and painful TMDs using the evidence-based methodology. A literature search was conducted using two electronic databases, Scopus, and PubMed. Risk of bias was assessed using the risk-of-bias assessment tool for non-randomized study version 2.0. A total of 158 articles were screened from the initial search and eventually, 5 articles were included in this systematic review. One study adopted both the longitudinal prospective cohort and case-control designs and other 4 articles adopted the cross-sectional design. Two studies employed polysomnography (PSG) for the diagnosis of OSA and mentioned the results from the PSG. All cross-sectional studies demonstrated higher OSA prevalence among patients with TMD, and one cohort study suggested OSA as a risk factor for TMD. OSA appears to have potential influences on the development of TMD; however, the role of TMD in the development of OSA remains to be unknown owing to the lack of high-quality evidences.

Go to :

Keywords: Obstructive sleep apnea, Temporomandibular disorder, Pain, Inflammation, Sleep fragmentation

I. Introduction

Temporomandibular disorder (TMD) is a collective term which includes pain conditions and functional disabilities occurring in the temporomandibular joint, masticatory muscles, and their surrounding structures¹. TMD can manifest high levels of its complexity via complicated pathophysiology and wide and variety spectrums of comorbidities including headache, chronic fatigue syndrome and so on^2,3.

Sleep disorders are among the well-known comorbidities of TMD, particularly painful TMDs^2,4-12. Sleep quality deterioration and chronic pain seem to have a bi-directional association; however, the influences of poor sleep quality on chronic pain are greater than those of chronic pain on sleep quality. Several studies demonstrated that poor sleep quality greatly exacerbated pain but chronic pain only minimally leaded to poor sleep quality^13,14. Therefore, for proper management of the painful TMD patients in TMD and orofacial pain clinics, thorough understanding of the complex pathophysiology of the sleep disorders and prompt diagnosis and treatment are necessary.

Obstructive sleep apnea (OSA) is one of the most prevalent sleep-related breathing disorders in the general population and it is accompanied by diverse types of comorbidities, such as cardiovascular diseases, cognitive impairment, traffic accident, depression, and increased risk of mortality^15-19. OSA may cause sleep fragmentation and nocturnal hypoxemia which is related to hyperalgesia. Several studies have attempted previously to reveal interactions between pain modulating mechanisms and sleep disorders in terms of aforementioned factors^17,20,21. It has also been reported that 36% of TMD patients that met the diagnostic criteria for insomnia and over 28% for OSA²². On the other hand, 51% of OSA patients exhibited signs and symptoms of TMD compared with normal controls²³. One prospective long-term cohort study suggested OSA as a risk factor for painful TMD in the long term²⁴. Even though, several evidences have been proposed to clarify the association between OSA and painful TMDs, there is no consensus on the relationship between these two different entities. Therefore, the purpose of this systematic review was to review the existing literatures and provide comprehensive synthesis of such literatures about OSA and painful TMDs based on the evidence-based methodology.

Go to :

II. Materials and Methods

1. Study design and registration

This systemic review was conducted in compliance with the Preferred Reporting Items for Systemic Review and Meta-Analysis (PRISMA) guidelines²⁵.

2. Eligibility criteria

This review included observation studies which evaluated the association between painful TMD and OSA in adults. Painful TMDs were assessed using validated diagnostic criteria and protocols including Diagnostic Criteria for TMD (DC/TMD) or Research Diagnostic Criteria for TMD (RDC/TMD). OSA was assessed through validated self-administered questionnaires, designed for screening OSA such as STOP-BANG questionnaires and/or level I-IV polysomnography (PSG).

The studies including pediatrics and/or adolescents, younger than 19 years old; studies with unvalidated diagnostic criteria for painful TMD and OSA; scoping, narrative and systematic literature reviews; case reports; animal studies; non-English language studies, and studies with confounding diagnosis including stroke, headache, bruxism, and/or depression were excluded.

3. Search strategies

A literature search was conducted using two electronic databases, namely, Scopus, and PubMed, from 1982 to 2022. Reference lists from relevant scoping, narrative, and systematic reviews or original articles were also search to identify further relevant literatures.

Multiple keywords and MeSH (Medical Subject Headings) terms related to OSA and painful TMD were used for the electronic search. The search strategies for Scopus and PubMed were listed in Table 1. Two reviewers (J.H.K. and J.K.L.) independently screened the title and abstract of the identified appropriate studies included in this systematic review. If both reviewer had inconsistent decisions regarding an article, such an article was excluded.

Table 1

Strategies for electronic search

Database	No.	Query	Results
Scopus	4	#1 AND #2 AND #3	77
	3	TITLE-ABS-KEY (“pain” OR “pains”)	897,524
	2	TITLE-ABS-KEY (“temporomandibular pain disorder” OR “temporo-mandibular pain disorder” OR “temporomandibular disorder” OR “temporomandibular disease” OR “temporomandibular dysfunction” OR “temporo-mandibular disorder” OR “temporo-mandibular disease” OR “temporo-mandibular dysfunction” OR “TMD” OR “TMDs” OR “temporomandibular joint disorder” OR “temporomandibular joint disease” OR “temporomandibular joint dysfunction” OR “temporo-mandibular joint disorder” OR “temporo-mandibular joint disease” OR “temporo-mandibular joint dysfunction” OR “TMJ” OR “TMJ disorder” OR “TMJD” OR “jaw disease” OR “jaw disorder” OR “mandible injur” OR “mandibular disease” OR “mandibular injury” OR “maxillary disease”)	29,275
	1	TITLE-ABS-KEY (“sleep apnea” OR “sleep apnoea” OR “obstructive sleep apnea” OR “obstructive sleep apnoea” OR “nocturnal apnea” OR “nocturnal apnoea” OR “sleep-disordered breath” OR “sleep-disorder breath” OR ((“OSA” OR “OSAHS” OR “SDB” OR “OSDB”) AND “sleep”) OR ((“upper airway resistant” OR “upper airway obstruction” OR “hypoxia”) AND “sleep”))	55,174
PubMed	4	#1 AND #2 AND #3	148
	3	“Pain”[mesh] OR “pain”[tiab] OR “pains”[tiab]	1,329,334
	2	“Temporomandibular Joint Disorders”[mesh] OR “Temporomandibular Joint Dysfunction Syndrome”[mesh] OR “temporomandibular pain disorder”[tiab] OR “temporo-mandibular pain disorder”[tiab] OR “temporomandibular disorder”[tiab] OR “temporomandibular disease”[tiab] OR “temporomandibular dysfunction”[tiab] OR “temporo-mandibular disorder”[tiab] OR “temporo-mandibular disease”[tiab] OR “temporo-mandibular dysfunction”[tiab] OR “TMD”[tiab] OR “TMDs”[tiab] OR “temporomandibular joint disorder”[tiab] OR “temporomandibular joint disease”[tiab] OR “temporomandibular joint dysfunction”[tiab] OR “temporo-mandibular joint disorder”[tiab] OR “temporo-mandibular joint disease”[tiab] OR “temporo-mandibular joint dysfunction”[tiab] OR “TMJ”[tiab] OR “TMJ disorder”[tiab] OR “TMJD”[tiab] OR “jaw disease”[tiab] OR “jaw disorder”[tiab] OR “mandible injur”[tiab] OR “mandibular disease”[tiab] OR “mandibular injur”[tiab] OR “maxillary disease”[tiab]	57,120
	1	“Sleep Apnea Syndromes”[mesh:noexp] OR “Sleep Apnea, Obstructive”[mesh:noexp] OR “sleep apnea”[tiab] OR “sleep apnoea”[tiab] OR “obstructive sleep apnea”[tiab] OR “obstructive sleep apnoea”[tiab] OR “nocturnal apnea”[tiab] OR “nocturnal apnoea”[tiab] OR “sleep-disordered breath”[tiab] OR “sleep-disorder breath”[tiab] OR ((“OSA”[tiab] OR “OSAHS”[tiab] OR “SDB”[tiab] OR “OSDB”[tiab]) AND “sleep”[tiab]) OR ((“upper airway resistan”[tiab] OR “upper airway obstructi”[tiab] OR “hypoxia”[tiab]) AND “sleep”[tiab])	80,660

4. Risk of bias assessment

One orofacial pain specialist (J.H.K.) and one librarian who as expertise in methodology and literature search evaluated the methodological quality of the eligible articles using the risk-of-bias assessment tool for non-randomized study (RoBANS) version 2.0²⁶. The RoBANS covers six areas; the selection of participants, confounding variables, the measurement of exposure, blinding of outcome assessment, incomplete outcome data, and selective outcome reporting. Each area of the RoBANS tool was judged as either ‘low’, ‘high’, or ‘unclear’ risk of bias. Two assessors independently evaluated the risk of bias of the articles based on the RoBANS tool, and items inconsistent with each other were determined via thorough discussion.

Go to :

III. Results

1. Literature selection and characteristics of the selective studies

A total of 77 articles from Scopus and 148 articles from PubMed database were identified. After removing duplicated articles, 158 articles were identified from the initial search. After the title and abstract screening and full-text assessment, 5 studies were finally included in this systematic review.(Fig. 1, Table 2) One study adopted both prospective cohort and case-control design²⁷, two studies used the cross-sectional case-control study design^22,28, and the other two studies adopted the cross-sectional study design^23,29. TMDs were diagnosed using the RDC/TMD^22,27,28 or DC/TMD criteria^23,29. Three studies employed overnight full-channel PSG to evaluate respiratory events and the sleep qualities whereas other two studies used self-administered questionnaires^23,29.

Fig. 1

The PRISMA (Preferred Reporting Items for Systemic Review and Meta-Analysis) flow chart.

Table 2

Descriptive characteristics of the included studies (n=5)

Study	Study design	Cases	Controls	Diagnostic criterial for painful TMD	Evaluation of sleep apnea and sleep quality	Major study findings
Alessandri-Bonetti et al.²³ (2021)	Cross-sectional	41 consecutive patients with OSA	41 healthy controls	DC/TMD	PSG, site of obstruction observed by DISE	• 51% of consecutive OSA patients presented TMD signs and/or symptoms and 32% of controls showed TMD signs and/or symptoms.
Dubrovsky et al.²⁸ (2014)	Case-control	124 females with myofascial TMD	46 females without myofascial TMD	RDC/TMD criteria	PSG, ESS	• TMD cases demonstrated higher levels of respiratory events and arousal. • TMD cases with chronic myofascial TMD presented mild sleep disturbance and mild increase in upper airway resistance. • The degree of sleep disturbance and upper airway resistance were associated with acute myofascial pain levels.
Lee et al.²⁹ (2022)	Cross-sectional	503 chronic TMD patients	180 healthy controls	DC/TMD axis I	PSQI, STOP-BANG, ESS	• PSQI scores were higher in patients compared to controls and poor sleep was more prevalent in TMD patients. • Patients with chronic TMD had a higher likelihood of OSA and showed higher daytime sleepiness.
Sanders et al.²⁷ (2013)	Prospective cohort Case-control	2,604 participants in cohort study 1,614 participants in the case-control study	Random sample of 102 controls with low likelihood of OSA	RDC/TMD criteria	PSQI, 4-itmes STOP screening questionnaire	• Prospective cohort study: 1st onset TMD was two times higher in the 60% participants with high likelihood of OSA. • Case control study: chronic TMD cases had 3-fold higher odd ratios of high likelihood of OSA.
Smith et al.²² (2009)	Cross-sectional	53 patients with myofascial TMD	-	RDC/TMD axis I	ISI, PSG, PSQI, ESS	• 89% of participants with myofascial TMD met the criteria for at least one sleep disorder and 43.4% of participants with myofascial TMD were diagnosed with more than 2 sleep disorders. • Prevalence of primary insomnia and sleep apnea was high in myofascial TMD patients. • The primary insomnia bay play a role in hyperalgesia in myofascial TMD patients.

(OSA: obstructive sleep apnea, DC/TMD: Diagnostic Criteria for Temporomandibular Disorders, PSG: polysomnography, DISE: drug induced sleep endoscopy, TMD: temporomandibular disorder, RDC/TMD: Research Diagnostic Criteria for TMD, ESS: excessive daytime sleepiness, PSQI: Pittsburg Sleep Quality Index, ISI: Insomnia Severity Index)

2. Methodological quality assessment of the included articles

Four studies clearly mentioned the inclusion criteria^22,27-29, whereas one study did not clearly state the inclusion criteria and basement assessment for controls²³. Two studies measured and controlled confounding factors^22,27, whereas three studies did not^23,28,29. All studies were conducted without employing blindness between the observers and participants, and between observers and evaluators^22,23,27-29.(Fig. 2, 3)

Fig. 2

RoBANS (risk-of-bias assessment tool for non-randomized study) graph.

Fig. 3

RoBANS (risk-of-bias assessment tool for non-randomized study) summary. Green: low risk of bias, Yellow: unclear risk of bias, Red: high risk of bias.

3. Results from individual studies

Three studies which employed overnight full channel PSG for assessing OSA showed that myofascial TMD patients presented higher levels of sleep disturbances, respiratory events and arousals^22,23,28. Two of the three studies reported precise PSG data about sleep quality, oxygen desaturation, and respiratory events^22,28 but the other study did not²³. One study suggested the primary insomnia as a potential risk factor for hyperalgesia and central sensitization in patients with myofascial TMD which was diagnosed using the RDC/TMD criteria²². Primary insomnia was found to be correlated with mechanical and thermal thresholds on the masseter muscle and forearm and the respiratory disturbance index with increased pressure pain thresholds on the forearm²². Another study demonstrated that patients with TMD had higher levels of respiratory events and arousal compared with controls and that the levels of sleep disturbance and upper airway resistance were associated with acute myofascial pain levels²³. One study that employed both cross-sectional and prospective cohort designs suggested that OSA was a potential risk factor for TMD but could not determine role of TMD on onset of OSA²⁷. The results from the longitudinal prospective cohort study demonstrated that 1st onset TMD was two times higher in the 60% participants with high likelihood OSA²⁷. This study also presented the results from the cross-sectional study indicating that chronic TMD cases exhibited 3-fold higher odds of high likelihood of OSA²⁷. However, this study used self-administered questionnaires to screen the risk of OSA and did not used the PSG. One cross-sectional study demonstrated that consecutive patients with OSA had increased risk of TMD. Conversely, another cross-sectional study showed that patients with chronic TMD had deteriorated sleep quality and increased risk of OSA²⁹. Hence, OSA appears to have potential influences on the development of TMD; however, the role of TMD in the development of OSA still remains unknown.

Go to :

IV. Discussion

The potential bi-directional association between pain and sleep-related breathing disorders has been a topic of interest for researchers and clinicians for the past decades. Co-occurrence of pain and OSA has been previously reported^30,31. Furthermore, it has been postulated that OSA patients experienced hyperalgesia due to fragmented sleep and hypoxemia, which enhanced peripheral and central pain sensitization, thus promoting inflammation, and increasing spontaneous pain^32,33. To the best of our knowledge, there have been sparse studies which tried to integrate the fragmented knowledge about the relationship between painful TMD and OSA. Therefore, the aim of this systematic review was to review the existing literatures which dealt with related topics and provide comprehensive and integrated knowledge about OSA and painful TMDs accordance with the evidence-based methodology.

The aforementioned results indicated that OSA could be one of the risk factors for painful TMD; however, the role of TMD in the development of OSA remained obscure. Increased respiratory arousal and sleep disturbance, particularly during slow-wave non-rapid eye movement (NREM) sleep, in OSA patients have been reported, previously^34,35. Sleep deprivation can cause myalgia and chronic fatigue and impairs descending pain-inhibition pathways that are crucial for controlling and coping with pain³⁶. Slow-wave NREM sleep seems to play a role in the suppression of cortisol activity in the feedback loop of the hypothalamus-pituitary-adrenal (HPA) axis³⁷. The chronic TMD patients exhibited altered HPA axis feedback mechanisms and increased pain intensity and pain-related jaw disability³⁸. Therefore, disrupted sleep architectures, especially, slow-wave sleep structure owing to OSA may have negative impacts on the maintenance of endocrinological homeostasis and descending pain inhibitory pathway, which may play a role in the pain-modulating mechanisms in chronic TMD. Altered HPA axis homeostasis could have interactions with the amplification of pain intensity and limited jaw function in patients with painful TMD.

Nocturnal oxygen desaturation in patients with OSA showed increased analgesic sensitivity to opioid³⁹. Oxygen desaturation during sleep seemed to play a role in the increased expression of pro-inflammatory cytokines, especially interkeukin-6 and tumor necrosis factor-α²¹. These pro-inflammatory cytokines are associated with the enhancement of transient receptor potential vanilloid 1 activity which may play a role in the development of hyperalgesia^40,41. Furthermore, some evidences have indicated that interleukin-6 could enhance of N-methyl-D-aspartate receptor activity which may result in impaired descending pain inhibitory pathways^42,43. Hence, the nocturnal hypoxic condition in patients with painful TMD can increase pain sensitivity and alter descending pain inhibitory pathway and which can eventually influence the occurrence of peripheral and central pain sensitization.

The majorities of studies dealing with pain disorders and OSA focused on the aforementioned two mechanisms, activity of pro-inflammatory cytokines and sleep fragmentation. However, one study suggested the other possibility. This study demonstrated that nocturnal arterial desaturation was related with an increased pain in subject with sleep-disordered breathing; however, such as association was not related to sleep fragmentation and inflammation. Owing to complicated pain modulating mechanisms, further investigations are warranted.

The influence of OSA management on pain outcome has been proposed in previous reports. The delivery of continuous positive airway pressure (CPAP) may improve pain intensity and tolerance^44-46, and the use of oral appliance can lessen the systemic inflammatory cytokine levels in patients with TMD⁴⁷. However, the use of CPAP and oral appliance to manage OSA in patients with painful TMD should be carefully considered as both may cause mask discomfort and orofacial pain at the initial stage of the therapy^48,49. Because no long-term well-designed randomized controlled trial has been conducted, the therapeutic effects of OSA treatment on painful TMD remains to be obscure.

To date, there has been no sufficient evidence proving the association between OSA and painful TMD. Furthermore, studies employing PSG, the gold standard for OSA diagnosis are scares and questionnaires for screening the risk of OSA are commonly used instead. Three studies included in this systematic review were published before 2016^22,27,28, therefore the DC/TMD criteria, the most current validated diagnostic criteria for TMD, could not be applied. Only one prospective cohort study has been conducted and majorities of the studies included in this review adopted cross-sectional design. In addition, quantitative sensory test data for the diagnosis of hyperalgesia was performed in only one cross-sectional study. Hence, to elucidate this topic, more longitudinal prospective cohort studies using full-channel overnight PSG data, TMD diagnosis based on the DC/TMD criteria, and quantitative sensory testing would be required.

Go to :

V. Conclusion

Evidences of the potential relationships between painful TMDs and OSA are inconclusive. In addition, due to the small number of well-designed prospective studies using proper diagnostic criteria for TMD and PSG, the causal relationships remain unclear. Furthermore, the therapeutic effects of OSA treatment on improvement of pain in TMD or vice versa have not been revealed. Future well-structured prospective cohort studies which include large sample size as well as randomized controlled trials would be warranted.

Go to :

Notes

Authors’ Contributions

J.H.K. and J.K.L. participated in conception and design of the study. J.H.K. analysis the data and performed statistical analysis. J.H.K. and J.K.L. wrote the manuscript. J.H.K. and J.K.L. edited and finally approved the manuscript. All authors approved the final version of the manuscript.

Conflict of Interest

No potential conflict of interest relevant to this article was reported.

Go to :

References

1. de Leeuw Reny, Klasser G. 2018. Orofacial pain: guidelines for assessment, diagnosis, and management. 6th ed. Quintessence;Batavia (IL):

2. Dahan H, Shir Y, Velly A, Allison P. 2015; Specific and number of comorbidities are associated with increased levels of temporomandibular pain intensity and duration. J Headache Pain. 16:528. https://doi.org/10.1186/s10194-015-0528-2. DOI: 10.1186/s10194-015-0528-2. PMID: 26002637. PMCID: PMC4441879.

3. Hoffmann RG, Kotchen JM, Kotchen TA, Cowley T, Dasgupta M, Cowley AW Jr. 2011; Temporomandibular disorders and associated clinical comorbidities. Clin J Pain. 27:268–74. https://doi.org/10.1097/AJP.0b013e31820215f5. DOI: 10.1097/AJP.0b013e31820215f5. PMID: 21178593.

4. Al-Jewair T, Shibeika D, Ohrbach R. 2021; Temporomandibular disorders and their association with sleep disorders in adults: a systematic review. J Oral Facial Pain Headache. 35:41–53. https://doi.org/10.11607/ofph.2780. DOI: 10.11607/ofph.2780. PMID: 33730126.

5. Almoznino G, Benoliel R, Sharav Y, Haviv Y. 2017; Sleep disorders and chronic craniofacial pain: characteristics and management possibilities. Sleep Med Rev. 33:39–50. https://doi.org/10.1016/j.smrv.2016.04.005. DOI: 10.1016/j.smrv.2016.04.005. PMID: 27321865.

6. Burr MR, Naze GS, Shaffer SM, Emerson AJ. 2021; The role of sleep dysfunction in temporomandibular onset and progression: a systematic review and meta-analyses. J Oral Rehabil. 48:183–94. https://doi.org/10.1111/joor.13127. DOI: 10.1111/joor.13127. PMID: 33211331.

7. Dreweck FDS, Soares S, Duarte J, Conti PCR, De Luca Canto G, Luís Porporatti A. 2020; Association between painful temporomandibular disorders and sleep quality: a systematic review. J Oral Rehabil. 47:1041–51. https://doi.org/10.1111/joor.12993. DOI: 10.1111/joor.12993. PMID: 32395855.

8. Kim HK, Kim ME. 2021; Phenotyping 1488 patients with painful temporomandibular disorders and its relevance to subjective sleep quality: a key step for stratified medicine. Cranio. 39:491–501. https://doi.org/10.1080/08869634.2019.1682750. DOI: 10.1080/08869634.2019.1682750. PMID: 31662051.

9. Lerman SF, Mun CJ, Hunt CA, Kunatharaju S, Buenaver LF, Finan PH, et al. 2022; Insomnia with objective short sleep duration in women with temporomandibular joint disorder: quantitative sensory testing, inflammation and clinical pain profiles. Sleep Med. 90:26–35. https://doi.org/10.1016/j.sleep.2022.01.004. DOI: 10.1016/j.sleep.2022.01.004. PMID: 35091170. PMCID: PMC8923986.

10. Roithmann CC, Silva CAGD, Pattussi MP, Grossi ML. 2021; Subjective sleep quality and temporomandibular disorders: systematic literature review and meta-analysis. J Oral Rehabil. 48:1380–94. https://doi.org/10.1111/joor.13265. DOI: 10.1111/joor.13265. PMID: 34599524.

11. Schütz TC, Andersen ML, Tufik S. 2009; The influence of orofacial pain on sleep pattern: a review of theory, animal models and future directions. Sleep Med. 10:822–8. https://doi.org/10.1016/j.sleep.2008.09.018. DOI: 10.1016/j.sleep.2008.09.018. PMID: 19195929.

12. Sommer I, Lavigne G, Ettlin DA. 2015; Review of self-reported instruments that measure sleep dysfunction in patients suffering from temporomandibular disorders and/or orofacial pain. Sleep Med. 16:27–38. https://doi.org/10.1016/j.sleep.2014.07.023. DOI: 10.1016/j.sleep.2014.07.023. PMID: 25547038.

13. Rener-Sitar K, John MT, Pusalavidyasagar SS, Bandyopadhyay D, Schiffman EL. 2016; Sleep quality in temporomandibular disorder cases. Sleep Med. 25:105–12. https://doi.org/10.1016/j.sleep.2016.06.031. DOI: 10.1016/j.sleep.2016.06.031. PMID: 27823702. PMCID: PMC5376270.

14. Yatani H, Studts J, Cordova M, Carlson CR, Okeson JP. 2002; Comparison of sleep quality and clinical and psychologic characteristics in patients with temporomandibular disorders. J Orofac Pain. 16:221–8. PMID: 12221738.

15. Kang J, Tian Z, Wei J, Mu Z, Liang J, Li M. 2022; Association between obstructive sleep apnea and Alzheimer's disease-related blood and cerebrospinal fluid biomarkers: a meta-analysis. J Clin Neurosci. 102:87–94. https://doi.org/10.1016/j.jocn.2022.06.004. DOI: 10.1016/j.jocn.2022.06.004. PMID: 35753156.

16. Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. 2008; Sleep apnea as an independent risk factor for all-cause mortality: the Busselton health study. Sleep. 31:1079–85. DOI: 10.5665/sleep/31.8.1079. PMID: 18714779. PMCID: PMC2542953.

17. Peker Y, Carlson J, Hedner J. 2006; Increased incidence of coronary artery disease in sleep apnoea: a long-term follow-up. Eur Respir J. 28:596–602. https://doi.org/10.1183/09031936.06.00107805. DOI: 10.1183/09031936.06.00107805. PMID: 16641120.

18. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. 2005; Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med. 353:2034–41. https://doi.org/10.1056/NEJMoa043104. DOI: 10.1056/NEJMoa043104. PMID: 16282178.

19. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ, et al. 2008; Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 31:1071–8. DOI: 10.5665/sleep/31.8.1071. PMID: 18714778. PMCID: PMC2542952.

20. Roehrs T, Hyde M, Blaisdell B, Greenwald M, Roth T. 2006; Sleep loss and REM sleep loss are hyperalgesic. Sleep. 29:145–51. https://doi.org/10.1093/sleep/29.2.145. DOI: 10.1093/sleep/29.2.145. PMID: 16494081.

21. Kaczmarski P, Karuga FF, Szmyd B, Sochal M, Białasiewicz P, Strzelecki D, et al. 2022; The role of inflammation, hypoxia, and opioid receptor expression in pain modulation in patients suffering from obstructive sleep apnea. Int J Mol Sci. 23:9080. https://doi.org/10.3390/ijms23169080. DOI: 10.3390/ijms23169080. PMID: 36012341. PMCID: PMC9409023.

22. Smith MT, Wickwire EM, Grace EG, Edwards RR, Buenaver LF, Peterson S, et al. 2009; Sleep disorders and their association with laboratory pain sensitivity in temporomandibular joint disorder. Sleep. 32:779–90. https://doi.org/10.1093/sleep/32.6.779. DOI: 10.1093/sleep/32.6.779. PMID: 19544755. PMCID: PMC2690566.

23. Alessandri-Bonetti A, Scarano E, Fiorita A, Cordaro M, Gallenzi P. 2021; Prevalence of signs and symptoms of temporo-mandibular disorder in patients with sleep apnea. Sleep Breath. 25:2001–6. https://doi.org/10.1007/s11325-021-02337-9. DOI: 10.1007/s11325-021-02337-9. PMID: 33674964.

24. Maixner W, Greenspan JD, Dubner R, Bair E, Mulkey F, Miller V, et al. 2011; Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain. 12(11 Suppl):T75–91. https://doi.org/10.1016/j.jpain.2011.09.002. DOI: 10.1016/j.jpain.2011.09.002. PMID: 22074754. PMCID: PMC3233841.

25. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. 2015; ; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 4:1. https://doi.org/10.1186/2046-4053-4-1. DOI: 10.1186/2046-4053-4-1. PMID: 25554246. PMCID: PMC4320440.

26. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, Jang BH, et al. 2013; Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 66:408–14. https://doi.org/10.1016/j.jclinepi.2012.09.016. DOI: 10.1016/j.jclinepi.2012.09.016. PMID: 23337781.

27. Sanders AE, Essick GK, Fillingim R, Knott C, Ohrbach R, Greenspan JD, et al. 2013; Sleep apnea symptoms and risk of temporomandibular disorder: OPPERA cohort. J Dent Res. 92(7 Suppl):70S–77S. https://doi.org/10.1177/0022034513488140. DOI: 10.1177/0022034513488140. PMID: 23690360. PMCID: PMC3706181.

28. Dubrovsky B, Raphael KG, Lavigne GJ, Janal MN, Sirois DA, Wigren PE, et al. 2014; Polysomnographic investigation of sleep and respiratory parameters in women with temporomandibular pain disorders. J Clin Sleep Med. 10:195–201. https://doi.org/10.5664/jcsm.3452. DOI: 10.5664/jcsm.3452. PMID: 24533003. PMCID: PMC3899322.

29. Lee YH, Auh QS, An JS, Kim T. 2022; Poorer sleep quality in patients with chronic temporomandibular disorders compared to healthy controls. BMC Musculoskelet Disord. 23:246. https://doi.org/10.1186/s12891-022-05195-y. DOI: 10.1186/s12891-022-05195-y. PMID: 35287633. PMCID: PMC8922910.

30. Jennum P, Drewes AM, Andreasen A, Nielsen KD. 1993; Sleep and other symptoms in primary fibromyalgia and in healthy controls. J Rheumatol. 20:1756–9. PMID: 8295190.

31. Olmos SR. 2016; Comorbidities of chronic facial pain and obstructive sleep apnea. Curr Opin Pulm Med. 22:570–5. DOI: 10.1097/MCP.0000000000000325. PMID: 27662470.

32. Doufas AG, Tian L, Davies MF, Warby SC. 2013; Nocturnal intermittent hypoxia is independently associated with pain in subjects suffering from sleep-disordered breathing. Anesthesiology. 119:1149–62. https://doi.org/10.1097/ALN.0b013e3182a951fc. DOI: 10.1097/ALN.0b013e3182a951fc. PMID: 24025612.

33. Lam KK, Kunder S, Wong J, Doufas AG, Chung F. 2016; Obstructive sleep apnea, pain, and opioids: is the riddle solved? Curr Opin Anaesthesiol. 29:134–40. https://doi.org/10.1097/ACO.0000000000000265. DOI: 10.1097/ACO.0000000000000265. PMID: 26545144. PMCID: PMC4927322.

34. Ratnavadivel R, Chau N, Stadler D, Yeo A, McEvoy RD, Catcheside PG. 2009; Marked reduction in obstructive sleep apnea severity in slow wave sleep. J Clin Sleep Med. 5:519–24. DOI: 10.5664/jcsm.27651. PMID: 20465017. PMCID: PMC2792966.

35. Bonnet MH, Arand DL. 2003; Clinical effects of sleep fragmentation versus sleep deprivation. Sleep Med Rev. 7:297–310. https://doi.org/10.1053/smrv.2001.0245. DOI: 10.1053/smrv.2001.0245. PMID: 14505597.

36. Choy EH. 2015; The role of sleep in pain and fibromyalgia. Nat Rev Rheumatol. 11:513–20. https://doi.org/10.1038/nrrheum.2015.56. DOI: 10.1038/nrrheum.2015.56. PMID: 25907704.

37. de Feijter M, Katimertzoglou A, Tiemensma J, Ikram MA, Luik AI. 2022; Polysomnography-estimated sleep and the negative feedback loop of the hypothalamic-pituitary-adrenal (HPA) axis. Psychoneuroendocrinology. 141:105749. https://doi.org/10.1016/j.psyneuen.2022.105749. DOI: 10.1016/j.psyneuen.2022.105749. PMID: 35427952.

38. Jo KB, Lee YJ, Lee IG, Lee SC, Park JY, Ahn RS. 2016; Association of pain intensity, pain-related disability, and depression with hypothalamus-pituitary-adrenal axis function in female patients with chronic temporomandibular disorders. Psychoneuroendocrinology. 69:106–15. https://doi.org/10.1016/j.psyneuen.2016.03.017. DOI: 10.1016/j.psyneuen.2016.03.017. PMID: 27082645.

39. Doufas AG, Tian L, Padrez KA, Suwanprathes P, Cardell JA, Maecker HT, et al. 2013; Experimental pain and opioid analgesia in volunteers at high risk for obstructive sleep apnea. PLoS One. 8:e54807. https://doi.org/10.1371/journal.pone.0054807. DOI: 10.1371/journal.pone.0054807. PMID: 23382975. PMCID: PMC3558510.

40. Fang D, Kong LY, Cai J, Li S, Liu XD, Han JS, et al. 2015; Interleukin-6-mediated functional upregulation of TRPV1 receptors in dorsal root ganglion neurons through the activation of JAK/PI3K signaling pathway: roles in the development of bone cancer pain in a rat model. Pain. 156:1124–44. https://doi.org/10.1097/j.pain.0000000000000158. DOI: 10.1097/j.pain.0000000000000158. PMID: 25775359.

41. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. 2003; Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation. 107:1129–34. https://doi.org/10.1161/01.cir.0000052627.99976.18. DOI: 10.1161/01.CIR.0000052627.99976.18. PMID: 12615790.

42. Kawasaki Y, Zhang L, Cheng JK, Ji RR. 2008; Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 28:5189–94. https://doi.org/10.1523/JNEUROSCI.3338-07.2008. DOI: 10.1523/JNEUROSCI.3338-07.2008. PMID: 18480275. PMCID: PMC2408767.

43. Ji RR, Nackley A, Huh Y, Terrando N, Maixner W. 2018; Neuroinflammation and central sensitization in chronic and widespread pain. Anesthesiology. 129:343–66. https://doi.org/10.1097/ALN.0000000000002130. DOI: 10.1097/ALN.0000000000002130. PMID: 29462012. PMCID: PMC6051899.

44. Goksan B, Gunduz A, Karadeniz D, Ağan K, Tascilar FN, Tan F, et al. 2009; Morning headache in sleep apnoea: clinical and polysomnographic evaluation and response to nasal continuous positive airway pressure. Cephalalgia. 29:635–41. https://doi.org/10.1111/j.1468-2982.2008.01781.x. DOI: 10.1111/j.1468-2982.2008.01781.x. PMID: 19187338.

45. Kallweit U, Hidalgo H, Uhl V, Sándor PS. 2011; Continuous positive airway pressure therapy is effective for migraines in sleep apnea syndrome. Neurology. 76:1189–91. https://doi.org/10.1212/WNL.0b013e318212aad0. DOI: 10.1212/WNL.0b013e318212aad0. PMID: 21444907.

46. Charokopos A, Card ME, Gunderson C, Steffens C, Bastian LA. 2018; The association of obstructive sleep apnea and pain outcomes in adults: a systematic review. Pain Med. 19(Suppl 1):S69–75. https://doi.org/10.1093/pm/pny140. DOI: 10.1093/pm/pny140. PMID: 30203008.

47. Oh JT, Chung JW. 2016; Inflammatory cytokine level in patients with obstructive sleep apnea and treatment outcome of oral appliance therapy. J Oral Med Pain. 41:126–32. DOI: 10.14476/jomp.2016.41.3.126.

48. Doff MH, Veldhuis SK, Hoekema A, Slater JJ, Wijkstra PJ, de Bont LG, et al. 2012; Long-term oral appliance therapy in obstructive sleep apnea syndrome: a controlled study on temporomandibular side effects. Clin Oral Investig. 16:689–97. https://doi.org/10.1007/s00784-011-0555-6. DOI: 10.1007/s00784-011-0555-6. PMID: 21538074.

49. El-Solh AA, Homish GG, Ditursi G, Lazarus J, Rao N, Adamo D, et al. 2017; A randomized crossover trial evaluating continuous positive airway pressure versus mandibular advancement device on health outcomes in veterans with posttraumatic stress disorder. J Clin Sleep Med. 13:1327–35. https://doi.org/10.5664/jcsm.6808. DOI: 10.5664/jcsm.6808. PMID: 29065960. PMCID: PMC5656482.

Go to :

TOOLS

Similar articles